Rank | Gene Set | Z-score |
---|---|---|
1 | definitive hemopoiesis (GO:0060216) | 8.34117919 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.30802308 |
3 | platelet dense granule organization (GO:0060155) | 6.74527935 |
4 | regulation of posttranscriptional gene silencing (GO:0060147) | 6.41190790 |
5 | regulation of gene silencing by miRNA (GO:0060964) | 6.41190790 |
6 | regulation of gene silencing by RNA (GO:0060966) | 6.41190790 |
7 | antigen processing and presentation via MHC class Ib (GO:0002475) | 6.18783448 |
8 | megakaryocyte development (GO:0035855) | 5.86008481 |
9 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.59671542 |
10 | endosome to melanosome transport (GO:0035646) | 5.24101271 |
11 | endosome to pigment granule transport (GO:0043485) | 5.24101271 |
12 | mature B cell differentiation involved in immune response (GO:0002313) | 5.20760668 |
13 | ribosomal small subunit assembly (GO:0000028) | 5.19359970 |
14 | phospholipid scrambling (GO:0017121) | 4.96291155 |
15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.86229168 |
16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.86229168 |
17 | necroptotic process (GO:0070266) | 4.29160770 |
18 | lymphoid progenitor cell differentiation (GO:0002320) | 4.28035511 |
19 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.22978080 |
20 | positive regulation of B cell differentiation (GO:0045579) | 4.16776216 |
21 | establishment of integrated proviral latency (GO:0075713) | 4.15188336 |
22 | polyketide metabolic process (GO:0030638) | 4.09196294 |
23 | doxorubicin metabolic process (GO:0044598) | 4.09196294 |
24 | daunorubicin metabolic process (GO:0044597) | 4.09196294 |
25 | secretory granule organization (GO:0033363) | 4.05867000 |
26 | lymph node development (GO:0048535) | 3.98024378 |
27 | DNA double-strand break processing (GO:0000729) | 3.93468188 |
28 | response to interferon-beta (GO:0035456) | 3.93142819 |
29 | response to interferon-alpha (GO:0035455) | 3.89197854 |
30 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.85521059 |
31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.82597169 |
32 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.78832963 |
33 | mature B cell differentiation (GO:0002335) | 3.75744955 |
34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.72241304 |
35 | response to protozoan (GO:0001562) | 3.70164847 |
36 | regulation of DNA endoreduplication (GO:0032875) | 3.69225720 |
37 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.67079172 |
38 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.67079172 |
39 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.67079172 |
40 | mitotic metaphase plate congression (GO:0007080) | 3.64446732 |
41 | defense response to protozoan (GO:0042832) | 3.62248028 |
42 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.60294066 |
43 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.60294066 |
44 | heparin biosynthetic process (GO:0030210) | 3.59734251 |
45 | heparin metabolic process (GO:0030202) | 3.59734251 |
46 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.55895607 |
47 | pre-miRNA processing (GO:0031054) | 3.55414391 |
48 | regulation of B cell differentiation (GO:0045577) | 3.52959592 |
49 | regulation of natural killer cell differentiation (GO:0032823) | 3.52888131 |
50 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.51692573 |
51 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.49058232 |
52 | chromatin remodeling at centromere (GO:0031055) | 3.46144378 |
53 | regulation of gene silencing (GO:0060968) | 3.44646473 |
54 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.41524298 |
55 | fucose catabolic process (GO:0019317) | 3.40304957 |
56 | L-fucose metabolic process (GO:0042354) | 3.40304957 |
57 | L-fucose catabolic process (GO:0042355) | 3.40304957 |
58 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.40276962 |
59 | cytokine production involved in immune response (GO:0002367) | 3.38160676 |
60 | response to type I interferon (GO:0034340) | 3.36808002 |
61 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.36053271 |
62 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.36053271 |
63 | type I interferon signaling pathway (GO:0060337) | 3.34258027 |
64 | cellular response to type I interferon (GO:0071357) | 3.34258027 |
65 | L-serine metabolic process (GO:0006563) | 3.34060799 |
66 | lysine catabolic process (GO:0006554) | 3.30809156 |
67 | lysine metabolic process (GO:0006553) | 3.30809156 |
68 | metaphase plate congression (GO:0051310) | 3.30618960 |
69 | regulation of helicase activity (GO:0051095) | 3.28970287 |
70 | angiogenesis involved in wound healing (GO:0060055) | 3.26118677 |
71 | negative regulation of gene silencing (GO:0060969) | 3.22480817 |
72 | viral transcription (GO:0019083) | 3.21716365 |
73 | CENP-A containing nucleosome assembly (GO:0034080) | 3.21178623 |
74 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.21139045 |
75 | establishment of viral latency (GO:0019043) | 3.20769922 |
76 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.19338043 |
77 | response to X-ray (GO:0010165) | 3.18882442 |
78 | immunoglobulin mediated immune response (GO:0016064) | 3.18761016 |
79 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.18349212 |
80 | Peyers patch development (GO:0048541) | 3.18349212 |
81 | T-helper 1 type immune response (GO:0042088) | 3.16356639 |
82 | programmed necrotic cell death (GO:0097300) | 3.15791446 |
83 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.15197281 |
84 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.15197281 |
85 | macrophage differentiation (GO:0030225) | 3.12387400 |
86 | thrombin receptor signaling pathway (GO:0070493) | 3.09041280 |
87 | mitotic sister chromatid cohesion (GO:0007064) | 3.08920707 |
88 | detection of bacterium (GO:0016045) | 3.08627128 |
89 | translational termination (GO:0006415) | 3.08349188 |
90 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.08258811 |
91 | regulation of hippo signaling (GO:0035330) | 3.05372289 |
92 | positive regulation of granulocyte differentiation (GO:0030854) | 3.05289168 |
93 | B cell differentiation (GO:0030183) | 3.04066747 |
94 | aspartate family amino acid catabolic process (GO:0009068) | 3.02286352 |
95 | protein localization to kinetochore (GO:0034501) | 3.02125132 |
96 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01410090 |
97 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.00901011 |
98 | regulation of erythrocyte differentiation (GO:0045646) | 2.99498379 |
99 | histone exchange (GO:0043486) | 2.97556489 |
100 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.97538962 |
101 | embryonic hemopoiesis (GO:0035162) | 2.97354539 |
102 | detection of other organism (GO:0098543) | 2.96585940 |
103 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.96055517 |
104 | non-recombinational repair (GO:0000726) | 2.96055517 |
105 | positive regulation of macrophage differentiation (GO:0045651) | 2.94342846 |
106 | microtubule depolymerization (GO:0007019) | 2.94276539 |
107 | positive regulation of respiratory burst (GO:0060267) | 2.93332634 |
108 | toxin transport (GO:1901998) | 2.93078173 |
109 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.92094320 |
110 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.91633639 |
111 | mast cell activation (GO:0045576) | 2.91630832 |
112 | T cell homeostasis (GO:0043029) | 2.91435014 |
113 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.90868720 |
114 | protein localization to chromosome, centromeric region (GO:0071459) | 2.89992461 |
115 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.89430164 |
116 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.89430164 |
117 | negative regulation of DNA recombination (GO:0045910) | 2.85322897 |
118 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.83296631 |
119 | isotype switching (GO:0045190) | 2.83296631 |
120 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.83296631 |
121 | necrotic cell death (GO:0070265) | 2.82771868 |
122 | regulation of natural killer cell activation (GO:0032814) | 2.82151865 |
123 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.80825356 |
124 | regulation of gamma-delta T cell activation (GO:0046643) | 2.80132242 |
125 | regulation of spindle checkpoint (GO:0090231) | 2.79992549 |
126 | mast cell activation involved in immune response (GO:0002279) | 2.77138658 |
127 | mast cell degranulation (GO:0043303) | 2.77138658 |
128 | myeloid dendritic cell activation (GO:0001773) | 2.77095853 |
129 | regulation of RIG-I signaling pathway (GO:0039535) | 2.76775716 |
130 | respiratory chain complex IV assembly (GO:0008535) | 2.76579578 |
131 | regulation of centriole replication (GO:0046599) | 2.76441693 |
132 | kidney morphogenesis (GO:0060993) | 2.75200435 |
133 | negative regulation of viral genome replication (GO:0045071) | 2.74920226 |
134 | histamine transport (GO:0051608) | 2.73776286 |
135 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.73607572 |
136 | spindle checkpoint (GO:0031577) | 2.73230696 |
137 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.72113247 |
138 | translational elongation (GO:0006414) | 2.71827335 |
139 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.70189881 |
140 | leukocyte homeostasis (GO:0001776) | 2.69424886 |
141 | positive regulation of natural killer cell activation (GO:0032816) | 2.69404529 |
142 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.69215770 |
143 | female gonad development (GO:0008585) | 2.69205461 |
144 | replication fork processing (GO:0031297) | 2.68573957 |
145 | amino acid salvage (GO:0043102) | 2.67778035 |
146 | L-methionine salvage (GO:0071267) | 2.67778035 |
147 | L-methionine biosynthetic process (GO:0071265) | 2.67778035 |
148 | glycoside metabolic process (GO:0016137) | 2.67204180 |
149 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.66626009 |
150 | mitotic spindle checkpoint (GO:0071174) | 2.64753552 |
151 | regulation of chromatin silencing (GO:0031935) | 2.63398975 |
152 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.63393446 |
153 | regulation of cofactor metabolic process (GO:0051193) | 2.63074449 |
154 | regulation of coenzyme metabolic process (GO:0051196) | 2.63074449 |
155 | dorsal/ventral axis specification (GO:0009950) | 2.63063683 |
156 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.62643076 |
157 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.62129604 |
158 | negative regulation of sister chromatid segregation (GO:0033046) | 2.62129604 |
159 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.62129604 |
160 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.62129604 |
161 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.62129604 |
162 | myeloid cell development (GO:0061515) | 2.62063542 |
163 | regulation of cell fate specification (GO:0042659) | 2.61801437 |
164 | single strand break repair (GO:0000012) | 2.61566452 |
165 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.61162525 |
166 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.60548798 |
167 | cotranslational protein targeting to membrane (GO:0006613) | 2.60113798 |
168 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.59213924 |
169 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.59173298 |
170 | response to thyroid hormone (GO:0097066) | 2.58883095 |
171 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.58383978 |
172 | nodal signaling pathway (GO:0038092) | 2.58274187 |
173 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.58252649 |
174 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.57546079 |
175 | negative regulation of chromosome segregation (GO:0051985) | 2.57480375 |
176 | kynurenine metabolic process (GO:0070189) | 2.57454688 |
177 | cytochrome complex assembly (GO:0017004) | 2.55303324 |
178 | ncRNA catabolic process (GO:0034661) | 2.53444238 |
179 | DNA ligation (GO:0006266) | 2.53196897 |
180 | presynaptic membrane assembly (GO:0097105) | 2.49278738 |
181 | nuclear pore complex assembly (GO:0051292) | 2.48564898 |
182 | DNA replication-independent nucleosome organization (GO:0034724) | 2.45510120 |
183 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.45510120 |
184 | DNA replication checkpoint (GO:0000076) | 2.45503811 |
185 | mitotic G2/M transition checkpoint (GO:0044818) | 2.42783156 |
186 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.42162194 |
187 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.42162194 |
188 | histone H2A acetylation (GO:0043968) | 2.41970826 |
189 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.41508795 |
190 | DNA strand renaturation (GO:0000733) | 2.40475010 |
191 | lung-associated mesenchyme development (GO:0060484) | 2.39199805 |
192 | nuclear pore organization (GO:0006999) | 2.39009223 |
193 | regulation of sulfur metabolic process (GO:0042762) | 2.38572031 |
194 | somatic diversification of immunoglobulins (GO:0016445) | 2.37858482 |
195 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.37325006 |
196 | regulation of chromosome segregation (GO:0051983) | 2.37243812 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 5.71908181 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.86628833 |
3 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.06384671 |
4 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.91868919 |
5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.75202239 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.73434698 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 3.66951656 |
8 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.63664192 |
9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.40356793 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.38980568 |
11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.25624254 |
12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.20989725 |
13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.19867937 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.08881970 |
15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.84187855 |
16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.78540827 |
17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.74320212 |
18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.73233339 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.67444654 |
20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.67250803 |
21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.63151519 |
22 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.62569385 |
23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51271253 |
24 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.45382102 |
25 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.44633615 |
26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.43313331 |
27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41699448 |
28 | VDR_22108803_ChIP-Seq_LS180_Human | 2.37299331 |
29 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.35461247 |
30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34208097 |
31 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.28960849 |
32 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.28329902 |
33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.26692559 |
34 | EWS_26573619_Chip-Seq_HEK293_Human | 2.25715182 |
35 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25340881 |
36 | FUS_26573619_Chip-Seq_HEK293_Human | 2.24285009 |
37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18138745 |
38 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.16292255 |
39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.15515376 |
40 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.12298844 |
41 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.11583642 |
42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11107084 |
43 | MYB_26560356_Chip-Seq_TH2_Human | 2.09557192 |
44 | * P300_19829295_ChIP-Seq_ESCs_Human | 2.08368048 |
45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.08335379 |
46 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.06748885 |
47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.05908366 |
48 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.05369001 |
49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.03430939 |
50 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.02945595 |
51 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.99517325 |
52 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.98905440 |
53 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.93042101 |
54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92397454 |
55 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89973404 |
56 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.89972073 |
57 | MYB_26560356_Chip-Seq_TH1_Human | 1.88018898 |
58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.86987760 |
59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.86189335 |
60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.84398663 |
61 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.83696778 |
62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.83595360 |
63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.83198069 |
64 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.81156355 |
65 | MYC_22102868_ChIP-Seq_BL_Human | 1.80643493 |
66 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.80022016 |
67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.79943994 |
68 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.79765049 |
69 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.79052540 |
70 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.77978118 |
71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.77532269 |
72 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.77388969 |
73 | MAF_26560356_Chip-Seq_TH1_Human | 1.76355353 |
74 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.74878226 |
75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72023791 |
76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.71187102 |
77 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70627308 |
78 | * SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.70422449 |
79 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.70005018 |
80 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.68619174 |
81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.67706025 |
82 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.63956273 |
83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62810004 |
84 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58443403 |
85 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.54437032 |
86 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.52540058 |
87 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.50297747 |
88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49173794 |
89 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.48593891 |
90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.46865556 |
91 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.45504558 |
92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44399297 |
93 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42950352 |
94 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38952863 |
95 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37862748 |
96 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.37223448 |
97 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.36740090 |
98 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.35266591 |
99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34551127 |
100 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33908139 |
101 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.33383338 |
102 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33308917 |
103 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33275144 |
104 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32673912 |
105 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32591461 |
106 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.31896145 |
107 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31043140 |
108 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27861134 |
109 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.27632075 |
110 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26643180 |
111 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25967397 |
112 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.25265119 |
113 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25089445 |
114 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24346206 |
115 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.24194134 |
116 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.23078208 |
117 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22680822 |
118 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22237988 |
119 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21634536 |
120 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.19928405 |
121 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19433152 |
122 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18637924 |
123 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16653871 |
124 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.16226522 |
125 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.14792415 |
126 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14674927 |
127 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.14664568 |
128 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14098085 |
129 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.13256972 |
130 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13225587 |
131 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12514298 |
132 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12147213 |
133 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12094959 |
134 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.10713237 |
135 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.10628999 |
136 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09847979 |
137 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.09448241 |
138 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09278133 |
139 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.09224517 |
140 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08861631 |
141 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.08618749 |
142 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08393287 |
143 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06947939 |
144 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06780530 |
145 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06680385 |
146 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06035147 |
147 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.06035147 |
148 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.05909869 |
149 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04937004 |
150 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04674830 |
151 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.04276553 |
152 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.04116853 |
153 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04067094 |
154 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04067094 |
155 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03882187 |
156 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03561025 |
157 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.03050086 |
158 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.02412264 |
159 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.02401023 |
160 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.02024647 |
161 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.01601626 |
162 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00534112 |
163 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00534112 |
164 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99696974 |
165 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97755167 |
166 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.97013429 |
167 | * POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.95588231 |
168 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95064375 |
169 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.94659275 |
170 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.94510858 |
171 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.94332816 |
172 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92914598 |
173 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.92737838 |
174 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91403467 |
175 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.91285408 |
176 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.91254395 |
177 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91212424 |
178 | AR_25329375_ChIP-Seq_VCAP_Human | 0.91015587 |
179 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90784623 |
180 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.90328569 |
181 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86823738 |
182 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86810942 |
183 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.86561455 |
184 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.84989415 |
185 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84023720 |
186 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83422256 |
187 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.83234808 |
188 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.82585426 |
189 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.80317726 |
190 | MAF_26560356_Chip-Seq_TH2_Human | 0.78189689 |
191 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.75918125 |
192 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.75253976 |
193 | AR_20517297_ChIP-Seq_VCAP_Human | 0.73980642 |
194 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73480910 |
195 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71842985 |
196 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71639716 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001986_abnormal_taste_sensitivity | 4.09828176 |
2 | MP0002396_abnormal_hematopoietic_system | 3.73794144 |
3 | MP0003693_abnormal_embryo_hatching | 3.36813348 |
4 | MP0008877_abnormal_DNA_methylation | 3.29553405 |
5 | MP0003195_calcinosis | 3.24103059 |
6 | MP0003890_abnormal_embryonic-extraembry | 3.10404734 |
7 | MP0008057_abnormal_DNA_replication | 3.09169569 |
8 | MP0005397_hematopoietic_system_phenotyp | 2.93044804 |
9 | MP0001545_abnormal_hematopoietic_system | 2.93044804 |
10 | MP0005174_abnormal_tail_pigmentation | 2.87840676 |
11 | MP0009785_altered_susceptibility_to | 2.86061578 |
12 | MP0004808_abnormal_hematopoietic_stem | 2.81010613 |
13 | MP0005464_abnormal_platelet_physiology | 2.77776866 |
14 | MP0003718_maternal_effect | 2.72027670 |
15 | MP0000685_abnormal_immune_system | 2.67317419 |
16 | MP0003724_increased_susceptibility_to | 2.66560320 |
17 | MP0001835_abnormal_antigen_presentation | 2.65056445 |
18 | MP0009278_abnormal_bone_marrow | 2.63710479 |
19 | MP0005075_abnormal_melanosome_morpholog | 2.58376063 |
20 | MP0004147_increased_porphyrin_level | 2.56224835 |
21 | MP0002837_dystrophic_cardiac_calcinosis | 2.54294487 |
22 | MP0000569_abnormal_digit_pigmentation | 2.53804529 |
23 | MP0003136_yellow_coat_color | 2.50326726 |
24 | MP0000465_gastrointestinal_hemorrhage | 2.37256391 |
25 | MP0008058_abnormal_DNA_repair | 2.36988492 |
26 | MP0010094_abnormal_chromosome_stability | 2.32897808 |
27 | MP0003646_muscle_fatigue | 2.26111386 |
28 | MP0003191_abnormal_cellular_cholesterol | 2.10813831 |
29 | MP0003436_decreased_susceptibility_to | 2.08222277 |
30 | MP0001293_anophthalmia | 2.07680166 |
31 | MP0004957_abnormal_blastocyst_morpholog | 2.05330910 |
32 | MP0002102_abnormal_ear_morphology | 2.04562669 |
33 | MP0005671_abnormal_response_to | 1.98435835 |
34 | MP0003866_abnormal_defecation | 1.96198777 |
35 | MP0002877_abnormal_melanocyte_morpholog | 1.95000866 |
36 | MP0003567_abnormal_fetal_cardiomyocyte | 1.92241879 |
37 | MP0001188_hyperpigmentation | 1.91335180 |
38 | MP0005025_abnormal_response_to | 1.90848488 |
39 | MP0010368_abnormal_lymphatic_system | 1.86129532 |
40 | MP0006072_abnormal_retinal_apoptosis | 1.84988297 |
41 | MP0004133_heterotaxia | 1.84407512 |
42 | MP0003111_abnormal_nucleus_morphology | 1.82744441 |
43 | MP0010155_abnormal_intestine_physiology | 1.80816181 |
44 | MP0002938_white_spotting | 1.80772206 |
45 | MP0006292_abnormal_olfactory_placode | 1.72870727 |
46 | MP0005253_abnormal_eye_physiology | 1.72076051 |
47 | MP0002095_abnormal_skin_pigmentation | 1.71146352 |
48 | MP0006054_spinal_hemorrhage | 1.70966357 |
49 | MP0003943_abnormal_hepatobiliary_system | 1.68332943 |
50 | MP0003077_abnormal_cell_cycle | 1.66336112 |
51 | MP0004264_abnormal_extraembryonic_tissu | 1.65518303 |
52 | MP0001800_abnormal_humoral_immune | 1.62877423 |
53 | MP0006035_abnormal_mitochondrial_morpho | 1.62441497 |
54 | MP0002723_abnormal_immune_serum | 1.62006450 |
55 | MP0003937_abnormal_limbs/digits/tail_de | 1.60391314 |
56 | MP0003787_abnormal_imprinting | 1.59211530 |
57 | MP0002398_abnormal_bone_marrow | 1.58904455 |
58 | MP0002148_abnormal_hypersensitivity_rea | 1.57975307 |
59 | MP0008932_abnormal_embryonic_tissue | 1.57519402 |
60 | MP0002653_abnormal_ependyma_morphology | 1.57436001 |
61 | MP0003119_abnormal_digestive_system | 1.56475673 |
62 | MP0000490_abnormal_crypts_of | 1.55471684 |
63 | MP0001853_heart_inflammation | 1.52530530 |
64 | MP0002420_abnormal_adaptive_immunity | 1.49540647 |
65 | MP0003868_abnormal_feces_composition | 1.49310596 |
66 | MP0001819_abnormal_immune_cell | 1.47872907 |
67 | MP0002419_abnormal_innate_immunity | 1.47508215 |
68 | MP0002452_abnormal_antigen_presenting | 1.46483079 |
69 | MP0005000_abnormal_immune_tolerance | 1.42803410 |
70 | MP0005551_abnormal_eye_electrophysiolog | 1.42678917 |
71 | MP0004215_abnormal_myocardial_fiber | 1.42520765 |
72 | MP0008875_abnormal_xenobiotic_pharmacok | 1.40382190 |
73 | MP0009764_decreased_sensitivity_to | 1.35448706 |
74 | MP0000689_abnormal_spleen_morphology | 1.33144334 |
75 | MP0003763_abnormal_thymus_physiology | 1.32660472 |
76 | MP0001873_stomach_inflammation | 1.31276321 |
77 | MP0001790_abnormal_immune_system | 1.29111406 |
78 | MP0005387_immune_system_phenotype | 1.29111406 |
79 | MP0004947_skin_inflammation | 1.28660834 |
80 | * MP0000716_abnormal_immune_system | 1.28461390 |
81 | MP0002166_altered_tumor_susceptibility | 1.27164030 |
82 | MP0001968_abnormal_touch/_nociception | 1.26644391 |
83 | MP0003121_genomic_imprinting | 1.25939111 |
84 | MP0001286_abnormal_eye_development | 1.25353630 |
85 | MP0001845_abnormal_inflammatory_respons | 1.24855032 |
86 | MP0009765_abnormal_xenobiotic_induced | 1.24047563 |
87 | MP0008469_abnormal_protein_level | 1.23955076 |
88 | * MP0002429_abnormal_blood_cell | 1.23010869 |
89 | MP0001529_abnormal_vocalization | 1.21885320 |
90 | MP0001324_abnormal_eye_pigmentation | 1.19661671 |
91 | MP0002722_abnormal_immune_system | 1.19214368 |
92 | MP0003300_gastrointestinal_ulcer | 1.18317598 |
93 | MP0002928_abnormal_bile_duct | 1.18122052 |
94 | MP0008775_abnormal_heart_ventricle | 1.17268227 |
95 | MP0005365_abnormal_bile_salt | 1.16784946 |
96 | MP0000647_abnormal_sebaceous_gland | 1.16556286 |
97 | MP0003638_abnormal_response/metabolism_ | 1.15771257 |
98 | MP0002090_abnormal_vision | 1.15592551 |
99 | MP0002735_abnormal_chemical_nociception | 1.15423044 |
100 | MP0005395_other_phenotype | 1.14502522 |
101 | MP0001485_abnormal_pinna_reflex | 1.14020075 |
102 | MP0009672_abnormal_birth_weight | 1.13965062 |
103 | MP0000343_altered_response_to | 1.12424280 |
104 | MP0005084_abnormal_gallbladder_morpholo | 1.11144910 |
105 | MP0009379_abnormal_foot_pigmentation | 1.11025847 |
106 | MP0004043_abnormal_pH_regulation | 1.09853345 |
107 | MP0004197_abnormal_fetal_growth/weight/ | 1.09070244 |
108 | MP0005167_abnormal_blood-brain_barrier | 1.09001232 |
109 | MP0002697_abnormal_eye_size | 1.08998695 |
110 | MP0000681_abnormal_thyroid_gland | 1.08567341 |
111 | MP0002405_respiratory_system_inflammati | 1.08273761 |
112 | MP0002084_abnormal_developmental_patter | 1.05864498 |
113 | MP0005391_vision/eye_phenotype | 1.05540522 |
114 | MP0005380_embryogenesis_phenotype | 1.05472124 |
115 | MP0001672_abnormal_embryogenesis/_devel | 1.05472124 |
116 | MP0000372_irregular_coat_pigmentation | 1.04151767 |
117 | MP0002736_abnormal_nociception_after | 1.03911161 |
118 | MP0004084_abnormal_cardiac_muscle | 1.03720474 |
119 | MP0006276_abnormal_autonomic_nervous | 1.03168499 |
120 | MP0002233_abnormal_nose_morphology | 1.02849785 |
121 | MP0003828_pulmonary_edema | 1.00367709 |
122 | MP0005085_abnormal_gallbladder_physiolo | 1.00139715 |
123 | MP0000516_abnormal_urinary_system | 0.98957610 |
124 | MP0005367_renal/urinary_system_phenotyp | 0.98957610 |
125 | MP0001984_abnormal_olfaction | 0.97063748 |
126 | MP0008789_abnormal_olfactory_epithelium | 0.96524043 |
127 | MP0003984_embryonic_growth_retardation | 0.95959901 |
128 | MP0003172_abnormal_lysosome_physiology | 0.95727224 |
129 | MP0002132_abnormal_respiratory_system | 0.95489649 |
130 | MP0000015_abnormal_ear_pigmentation | 0.94525440 |
131 | MP0002088_abnormal_embryonic_growth/wei | 0.94382265 |
132 | MP0003075_altered_response_to | 0.93829253 |
133 | MP0001730_embryonic_growth_arrest | 0.93288369 |
134 | MP0009703_decreased_birth_body | 0.93058190 |
135 | MP0010234_abnormal_vibrissa_follicle | 0.92247797 |
136 | MP0002085_abnormal_embryonic_tissue | 0.91414491 |
137 | * MP0005332_abnormal_amino_acid | 0.89962563 |
138 | MP0001879_abnormal_lymphatic_vessel | 0.89919254 |
139 | MP0003806_abnormal_nucleotide_metabolis | 0.89220856 |
140 | MP0001697_abnormal_embryo_size | 0.88522594 |
141 | MP0002254_reproductive_system_inflammat | 0.88341449 |
142 | MP0008007_abnormal_cellular_replicative | 0.88286921 |
143 | MP0010352_gastrointestinal_tract_polyps | 0.87935290 |
144 | MP0003137_abnormal_impulse_conducting | 0.87925728 |
145 | MP0003183_abnormal_peptide_metabolism | 0.87798456 |
146 | MP0009046_muscle_twitch | 0.86550543 |
147 | MP0005195_abnormal_posterior_eye | 0.85690653 |
148 | MP0002693_abnormal_pancreas_physiology | 0.85507521 |
149 | MP0003122_maternal_imprinting | 0.83410002 |
150 | MP0000358_abnormal_cell_content/ | 0.82465146 |
151 | MP0003656_abnormal_erythrocyte_physiolo | 0.81905843 |
152 | MP0001348_abnormal_lacrimal_gland | 0.80765288 |
153 | MP0001533_abnormal_skeleton_physiology | 0.80409674 |
154 | MP0002006_tumorigenesis | 0.79854400 |
155 | MP0009763_increased_sensitivity_to | 0.78837738 |
156 | MP0008004_abnormal_stomach_pH | 0.78468318 |
157 | MP0008874_decreased_physiological_sensi | 0.77764002 |
158 | MP0005408_hypopigmentation | 0.76819428 |
159 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76290400 |
160 | MP0005394_taste/olfaction_phenotype | 0.73518634 |
161 | MP0005499_abnormal_olfactory_system | 0.73518634 |
162 | MP0000477_abnormal_intestine_morphology | 0.73284230 |
163 | MP0000703_abnormal_thymus_morphology | 0.73090246 |
164 | MP0001929_abnormal_gametogenesis | 0.73061015 |
165 | MP0003861_abnormal_nervous_system | 0.72690905 |
166 | MP0000537_abnormal_urethra_morphology | 0.72580509 |
167 | MP0003941_abnormal_skin_development | 0.71719985 |
168 | MP0000678_abnormal_parathyroid_gland | 0.71657422 |
169 | MP0001666_abnormal_nutrient_absorption | 0.71513049 |
170 | MP0002638_abnormal_pupillary_reflex | 0.71367849 |
171 | MP0005409_darkened_coat_color | 0.71217329 |
172 | MP0010329_abnormal_lipoprotein_level | 0.71091768 |
173 | MP0005379_endocrine/exocrine_gland_phen | 0.70879333 |
174 | MP0009697_abnormal_copulation | 0.70672996 |
175 | MP0002111_abnormal_tail_morphology | 0.70480214 |
176 | MP0002138_abnormal_hepatobiliary_system | 0.70197649 |
177 | MP0000631_abnormal_neuroendocrine_gland | 0.70049161 |
178 | MP0002751_abnormal_autonomic_nervous | 0.69906003 |
179 | MP0004085_abnormal_heartbeat | 0.69436366 |
180 | MP0000598_abnormal_liver_morphology | 0.69338455 |
181 | MP0009643_abnormal_urine_homeostasis | 0.69235456 |
182 | MP0001145_abnormal_male_reproductive | 0.68567590 |
183 | MP0005171_absent_coat_pigmentation | 0.67131254 |
184 | MP0003755_abnormal_palate_morphology | 0.67099766 |
185 | MP0002080_prenatal_lethality | 0.66392973 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Thrombocytosis (HP:0001894) | 4.66460361 |
2 | Hypothermia (HP:0002045) | 4.61389994 |
3 | Myositis (HP:0100614) | 4.48762255 |
4 | Prolonged bleeding time (HP:0003010) | 4.35270841 |
5 | Aplastic anemia (HP:0001915) | 4.19536196 |
6 | IgM deficiency (HP:0002850) | 3.92241049 |
7 | Interstitial pulmonary disease (HP:0006530) | 3.82419074 |
8 | Acute myeloid leukemia (HP:0004808) | 3.72918196 |
9 | Abnormality of the labia minora (HP:0012880) | 3.69205136 |
10 | Epistaxis (HP:0000421) | 3.68012763 |
11 | Hypoproteinemia (HP:0003075) | 3.55564783 |
12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.54609069 |
13 | Chronic otitis media (HP:0000389) | 3.42785815 |
14 | Petechiae (HP:0000967) | 3.13332240 |
15 | Acute lymphatic leukemia (HP:0006721) | 3.12486758 |
16 | Impaired platelet aggregation (HP:0003540) | 3.06293038 |
17 | Abnormal platelet function (HP:0011869) | 3.06293038 |
18 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.05920166 |
19 | Reduced antithrombin III activity (HP:0001976) | 3.03696978 |
20 | Orchitis (HP:0100796) | 3.02143726 |
21 | Episodic fever (HP:0001954) | 2.88755180 |
22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.88747214 |
23 | Gingival bleeding (HP:0000225) | 2.88044400 |
24 | Hyperglycinemia (HP:0002154) | 2.85342597 |
25 | Abnormal number of erythroid precursors (HP:0012131) | 2.82182903 |
26 | Generalized aminoaciduria (HP:0002909) | 2.79696503 |
27 | Erythema (HP:0010783) | 2.79277745 |
28 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.79044448 |
29 | Intestinal atresia (HP:0011100) | 2.78399279 |
30 | Increased IgE level (HP:0003212) | 2.76222103 |
31 | Hyperglycinuria (HP:0003108) | 2.72668722 |
32 | Abnormality of the nasal mucosa (HP:0000433) | 2.72504533 |
33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.71036466 |
34 | True hermaphroditism (HP:0010459) | 2.69575244 |
35 | Abnormality of T cell physiology (HP:0011840) | 2.69161581 |
36 | Pancreatic fibrosis (HP:0100732) | 2.64329634 |
37 | Hematochezia (HP:0002573) | 2.62218565 |
38 | Polygenic inheritance (HP:0010982) | 2.61942918 |
39 | Chronic hepatic failure (HP:0100626) | 2.59927871 |
40 | Abnormality of glycine metabolism (HP:0010895) | 2.58699852 |
41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.58699852 |
42 | Pancreatic cysts (HP:0001737) | 2.57797509 |
43 | Type I transferrin isoform profile (HP:0003642) | 2.56776972 |
44 | Cortical dysplasia (HP:0002539) | 2.55503485 |
45 | Lip pit (HP:0100267) | 2.54268659 |
46 | Spontaneous hematomas (HP:0007420) | 2.53835434 |
47 | Amaurosis fugax (HP:0100576) | 2.50125356 |
48 | Arterial thrombosis (HP:0004420) | 2.49200847 |
49 | Abnormality of midbrain morphology (HP:0002418) | 2.47805281 |
50 | Molar tooth sign on MRI (HP:0002419) | 2.47805281 |
51 | Colon cancer (HP:0003003) | 2.46396173 |
52 | Menorrhagia (HP:0000132) | 2.41358493 |
53 | Hyperlipoproteinemia (HP:0010980) | 2.38600812 |
54 | Pendular nystagmus (HP:0012043) | 2.37180829 |
55 | Abnormality of serum amino acid levels (HP:0003112) | 2.37073418 |
56 | Optic neuritis (HP:0100653) | 2.36785987 |
57 | Retrobulbar optic neuritis (HP:0100654) | 2.36785987 |
58 | Abolished electroretinogram (ERG) (HP:0000550) | 2.35832631 |
59 | Birth length less than 3rd percentile (HP:0003561) | 2.34046641 |
60 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.32118170 |
61 | Recurrent bronchitis (HP:0002837) | 2.31557308 |
62 | Albinism (HP:0001022) | 2.31497030 |
63 | Abnormality of macrophages (HP:0004311) | 2.30455012 |
64 | Abnormal protein glycosylation (HP:0012346) | 2.27513244 |
65 | Abnormal glycosylation (HP:0012345) | 2.27513244 |
66 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.27513244 |
67 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.27513244 |
68 | Gastrointestinal inflammation (HP:0004386) | 2.24954640 |
69 | Nephronophthisis (HP:0000090) | 2.23727655 |
70 | Vacuolated lymphocytes (HP:0001922) | 2.23554143 |
71 | Panhypogammaglobulinemia (HP:0003139) | 2.22990314 |
72 | Abnormality of chromosome stability (HP:0003220) | 2.22751183 |
73 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.20425102 |
74 | Inflammation of the large intestine (HP:0002037) | 2.20364511 |
75 | Meckel diverticulum (HP:0002245) | 2.19635268 |
76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.19278479 |
77 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.18275911 |
78 | Spontaneous abortion (HP:0005268) | 2.18128301 |
79 | Broad face (HP:0000283) | 2.17253741 |
80 | Portal hypertension (HP:0001409) | 2.16761961 |
81 | Ependymoma (HP:0002888) | 2.16114610 |
82 | Spastic diplegia (HP:0001264) | 2.14928233 |
83 | Supernumerary spleens (HP:0009799) | 2.12378336 |
84 | Bilateral microphthalmos (HP:0007633) | 2.12315271 |
85 | Methylmalonic acidemia (HP:0002912) | 2.12023761 |
86 | Bile duct proliferation (HP:0001408) | 2.11936401 |
87 | Abnormal biliary tract physiology (HP:0012439) | 2.11936401 |
88 | Chronic bronchitis (HP:0004469) | 2.11842061 |
89 | Abnormality of the ileum (HP:0001549) | 2.11806167 |
90 | Embryonal renal neoplasm (HP:0011794) | 2.11020934 |
91 | Purpura (HP:0000979) | 2.10188140 |
92 | Recurrent abscess formation (HP:0002722) | 2.09668258 |
93 | Growth hormone excess (HP:0000845) | 2.09323356 |
94 | Progressive neurologic deterioration (HP:0002344) | 2.09165976 |
95 | Hepatoblastoma (HP:0002884) | 2.09160588 |
96 | Anophthalmia (HP:0000528) | 2.08827188 |
97 | Chromsome breakage (HP:0040012) | 2.08772343 |
98 | Cellulitis (HP:0100658) | 2.08580954 |
99 | Progressive inability to walk (HP:0002505) | 2.08139761 |
100 | Beaking of vertebral bodies (HP:0004568) | 2.08090541 |
101 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.07550006 |
102 | Abnormality of alanine metabolism (HP:0010916) | 2.07550006 |
103 | Hyperalaninemia (HP:0003348) | 2.07550006 |
104 | Bruising susceptibility (HP:0000978) | 2.05684965 |
105 | Volvulus (HP:0002580) | 2.02836305 |
106 | Absent/shortened dynein arms (HP:0200106) | 2.01841776 |
107 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.01841776 |
108 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.01333042 |
109 | Medial flaring of the eyebrow (HP:0010747) | 2.00170793 |
110 | Abnormality of the hepatic vasculature (HP:0006707) | 1.99225272 |
111 | Vaginal atresia (HP:0000148) | 1.98967362 |
112 | Genital tract atresia (HP:0001827) | 1.98716189 |
113 | Recurrent bacterial skin infections (HP:0005406) | 1.98641918 |
114 | Myelodysplasia (HP:0002863) | 1.98600440 |
115 | Thyroid-stimulating hormone excess (HP:0002925) | 1.98500545 |
116 | Biliary tract neoplasm (HP:0100574) | 1.97093028 |
117 | Abnormality of the renal medulla (HP:0100957) | 1.97026036 |
118 | Abnormal lung lobation (HP:0002101) | 1.96821379 |
119 | Absent eyebrow (HP:0002223) | 1.96570833 |
120 | Abnormality of B cell number (HP:0010975) | 1.96337409 |
121 | B lymphocytopenia (HP:0010976) | 1.96337409 |
122 | Bifid tongue (HP:0010297) | 1.96150778 |
123 | Abnormality of the columella (HP:0009929) | 1.95672634 |
124 | Gastrointestinal stroma tumor (HP:0100723) | 1.94936300 |
125 | Spinal canal stenosis (HP:0003416) | 1.93606770 |
126 | Abnormality of methionine metabolism (HP:0010901) | 1.93096831 |
127 | Sloping forehead (HP:0000340) | 1.92309380 |
128 | Neoplasm of the adrenal gland (HP:0100631) | 1.91898310 |
129 | Recurrent fungal infections (HP:0002841) | 1.91709346 |
130 | Nonprogressive disorder (HP:0003680) | 1.91173531 |
131 | Anencephaly (HP:0002323) | 1.90765669 |
132 | Nephrogenic diabetes insipidus (HP:0009806) | 1.88712995 |
133 | Dandy-Walker malformation (HP:0001305) | 1.87950888 |
134 | Colitis (HP:0002583) | 1.87677650 |
135 | Congenital primary aphakia (HP:0007707) | 1.87490809 |
136 | Delayed CNS myelination (HP:0002188) | 1.87361985 |
137 | Tubulointerstitial nephritis (HP:0001970) | 1.86093980 |
138 | Thrombophlebitis (HP:0004418) | 1.85990995 |
139 | Hypoglycemic coma (HP:0001325) | 1.85888198 |
140 | Methylmalonic aciduria (HP:0012120) | 1.85818678 |
141 | Nasal polyposis (HP:0100582) | 1.85083045 |
142 | Keratitis (HP:0000491) | 1.85010381 |
143 | Septo-optic dysplasia (HP:0100842) | 1.83290323 |
144 | Microcytic anemia (HP:0001935) | 1.83250173 |
145 | Renal hypoplasia (HP:0000089) | 1.83110129 |
146 | Absent radius (HP:0003974) | 1.83020836 |
147 | Type 2 muscle fiber atrophy (HP:0003554) | 1.81880964 |
148 | Dysautonomia (HP:0002459) | 1.81871529 |
149 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.81489398 |
150 | Cupped ear (HP:0000378) | 1.80681335 |
151 | Abnormality of vitamin B metabolism (HP:0004340) | 1.80368187 |
152 | Poikiloderma (HP:0001029) | 1.80344298 |
153 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.79978594 |
154 | Vasculitis (HP:0002633) | 1.79459539 |
155 | Lissencephaly (HP:0001339) | 1.79135804 |
156 | Neoplasm of the adrenal cortex (HP:0100641) | 1.78518794 |
157 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.77904250 |
158 | Hypoplasia of the fovea (HP:0007750) | 1.77904250 |
159 | Decreased circulating renin level (HP:0003351) | 1.77877745 |
160 | Hypoplastic female external genitalia (HP:0012815) | 1.77823822 |
161 | Central scotoma (HP:0000603) | 1.77750811 |
162 | Aqueductal stenosis (HP:0002410) | 1.77463498 |
163 | Keratoconjunctivitis sicca (HP:0001097) | 1.77013188 |
164 | Broad-based gait (HP:0002136) | 1.76924719 |
165 | Cheilitis (HP:0100825) | 1.76893873 |
166 | Osteomyelitis (HP:0002754) | 1.76891605 |
167 | Abnormality of the duodenum (HP:0002246) | 1.76294725 |
168 | Gait imbalance (HP:0002141) | 1.76148283 |
169 | Hypoplasia of the thymus (HP:0000778) | 1.75974212 |
170 | Hyperpituitarism (HP:0010514) | 1.75973347 |
171 | Encephalitis (HP:0002383) | 1.75411701 |
172 | Bronchitis (HP:0012387) | 1.74856067 |
173 | Labial hypoplasia (HP:0000066) | 1.74844990 |
174 | Autoamputation (HP:0001218) | 1.74371329 |
175 | Rhabdomyosarcoma (HP:0002859) | 1.74099388 |
176 | Protruding tongue (HP:0010808) | 1.73917407 |
177 | Eczematoid dermatitis (HP:0000976) | 1.73669428 |
178 | Hyperventilation (HP:0002883) | 1.73525505 |
179 | Depressed nasal tip (HP:0000437) | 1.73488260 |
180 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.73467887 |
181 | Chorioretinal atrophy (HP:0000533) | 1.72742419 |
182 | Preaxial hand polydactyly (HP:0001177) | 1.72730389 |
183 | Hypobetalipoproteinemia (HP:0003563) | 1.72529332 |
184 | Absent forearm bone (HP:0003953) | 1.71820127 |
185 | Aplasia involving forearm bones (HP:0009822) | 1.71820127 |
186 | Recurrent viral infections (HP:0004429) | 1.71536060 |
187 | Abnormal hair whorl (HP:0010721) | 1.71516623 |
188 | Broad foot (HP:0001769) | 1.71407426 |
189 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.71216395 |
190 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.71110299 |
191 | Stenosis of the external auditory canal (HP:0000402) | 1.69708778 |
192 | Scrotal hypoplasia (HP:0000046) | 1.69438829 |
193 | Neoplasm of the colon (HP:0100273) | 1.67907864 |
194 | Proximal tubulopathy (HP:0000114) | 1.66673160 |
195 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.65920033 |
196 | Gastrointestinal atresia (HP:0002589) | 1.65795804 |
197 | Abnormality of the fovea (HP:0000493) | 1.65021507 |
198 | Hypoglycemic seizures (HP:0002173) | 1.65000220 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FLT3 | 5.00472727 |
2 | KIT | 4.02099494 |
3 | MAP2K3 | 2.80023766 |
4 | TGFBR1 | 2.75405770 |
5 | MATK | 2.70863512 |
6 | TNIK | 2.64370975 |
7 | WNK3 | 2.59814881 |
8 | ZAK | 2.49210159 |
9 | MKNK2 | 2.41405937 |
10 | MAP3K12 | 2.38552962 |
11 | TTK | 2.38199127 |
12 | TGFBR2 | 2.32485503 |
13 | NEK1 | 2.29386312 |
14 | MAPKAPK3 | 2.25706301 |
15 | TIE1 | 2.24246936 |
16 | STK38L | 2.23858694 |
17 | PLK3 | 2.21959262 |
18 | TEC | 2.19651137 |
19 | BUB1 | 2.19193956 |
20 | CASK | 2.17390723 |
21 | ACVR1B | 2.11567497 |
22 | NUAK1 | 2.11214748 |
23 | SRPK1 | 2.10787505 |
24 | MAP3K6 | 2.10343640 |
25 | BTK | 2.08446304 |
26 | CDC7 | 2.06715091 |
27 | MKNK1 | 2.03402954 |
28 | TSSK6 | 1.94959486 |
29 | CSF1R | 1.93832608 |
30 | RIPK4 | 1.92735867 |
31 | TRIM28 | 1.90776470 |
32 | PLK4 | 1.84468431 |
33 | TRPM7 | 1.83271037 |
34 | MAP4K1 | 1.83186429 |
35 | NME2 | 1.81826602 |
36 | JAK3 | 1.78995580 |
37 | BCR | 1.76651563 |
38 | EEF2K | 1.68732314 |
39 | NLK | 1.66381205 |
40 | ADRBK2 | 1.64822345 |
41 | TAF1 | 1.64596416 |
42 | EIF2AK3 | 1.62426973 |
43 | ERBB4 | 1.59396555 |
44 | LATS1 | 1.54743251 |
45 | TAOK3 | 1.53817589 |
46 | RPS6KB2 | 1.53002369 |
47 | VRK2 | 1.52891696 |
48 | MAP2K6 | 1.50539701 |
49 | PBK | 1.48050365 |
50 | ZAP70 | 1.46803008 |
51 | BCKDK | 1.44797536 |
52 | PRKG2 | 1.44250564 |
53 | CSNK1G1 | 1.41911446 |
54 | BRSK2 | 1.40384779 |
55 | PLK1 | 1.35807406 |
56 | FGFR4 | 1.33740314 |
57 | TBK1 | 1.30825713 |
58 | MAPK15 | 1.28981695 |
59 | MAPKAPK5 | 1.28331947 |
60 | CAMKK2 | 1.23093099 |
61 | PIM2 | 1.22718524 |
62 | GRK1 | 1.19224245 |
63 | STK3 | 1.18272617 |
64 | RIPK1 | 1.17886932 |
65 | MAP4K2 | 1.16761319 |
66 | MAP3K4 | 1.16592970 |
67 | NEK2 | 1.15240055 |
68 | IKBKE | 1.14419003 |
69 | EPHA3 | 1.14199087 |
70 | PLK2 | 1.12082825 |
71 | EIF2AK1 | 1.11947609 |
72 | MUSK | 1.11481907 |
73 | CSNK1G3 | 1.11047502 |
74 | DYRK2 | 1.07890730 |
75 | PDK2 | 1.07674364 |
76 | OXSR1 | 1.07259851 |
77 | CSNK1G2 | 1.06492572 |
78 | SIK3 | 1.05490418 |
79 | CSNK1A1L | 1.03696872 |
80 | SYK | 1.03484174 |
81 | WEE1 | 0.98277710 |
82 | HIPK2 | 0.94907182 |
83 | RET | 0.94555405 |
84 | LRRK2 | 0.92902564 |
85 | BRSK1 | 0.92469742 |
86 | TXK | 0.92213936 |
87 | FES | 0.88398768 |
88 | FGFR3 | 0.86926536 |
89 | IKBKB | 0.85360250 |
90 | CHEK2 | 0.82814926 |
91 | ATM | 0.82412189 |
92 | MAP2K4 | 0.82044820 |
93 | TYK2 | 0.81389083 |
94 | EPHB1 | 0.80090914 |
95 | INSRR | 0.80060988 |
96 | PASK | 0.79853225 |
97 | MAP3K2 | 0.78061938 |
98 | CAMK1D | 0.78038892 |
99 | ATR | 0.77811486 |
100 | MAP3K1 | 0.76300037 |
101 | PRKCE | 0.74060029 |
102 | CAMK1G | 0.71964798 |
103 | AURKB | 0.70595743 |
104 | ERN1 | 0.70399790 |
105 | ERBB3 | 0.69879349 |
106 | STK10 | 0.69214907 |
107 | CDK19 | 0.68619323 |
108 | BMPR1B | 0.67158998 |
109 | PAK3 | 0.66836676 |
110 | MYLK | 0.66078796 |
111 | STK16 | 0.65813025 |
112 | PAK4 | 0.63279956 |
113 | IRAK4 | 0.63257582 |
114 | LCK | 0.61873905 |
115 | LYN | 0.61723318 |
116 | PKN2 | 0.60978696 |
117 | WNK4 | 0.60162177 |
118 | MAP2K2 | 0.59940788 |
119 | OBSCN | 0.59671673 |
120 | FRK | 0.57201077 |
121 | ADRBK1 | 0.56816489 |
122 | CAMK1 | 0.56447718 |
123 | RAF1 | 0.55366110 |
124 | FER | 0.55118017 |
125 | NTRK1 | 0.54917752 |
126 | YES1 | 0.54831476 |
127 | PIK3CG | 0.53915681 |
128 | DAPK1 | 0.53448082 |
129 | MAP3K14 | 0.52632995 |
130 | CCNB1 | 0.51931634 |
131 | STK4 | 0.51452839 |
132 | PIM1 | 0.50993878 |
133 | EIF2AK2 | 0.50041017 |
134 | CDK8 | 0.48523041 |
135 | BRD4 | 0.48400559 |
136 | PINK1 | 0.47752765 |
137 | HCK | 0.47020582 |
138 | MAP3K7 | 0.46186541 |
139 | FGFR1 | 0.46150516 |
140 | DYRK3 | 0.44863691 |
141 | MAP3K3 | 0.44448005 |
142 | CHUK | 0.44221132 |
143 | KDR | 0.43400202 |
144 | MAPK4 | 0.42221582 |
145 | CHEK1 | 0.41299293 |
146 | FGFR2 | 0.40725607 |
147 | IRAK3 | 0.40236765 |
148 | LMTK2 | 0.39947834 |
149 | STK24 | 0.39909609 |
150 | ITK | 0.39111765 |
151 | CSNK1A1 | 0.38625073 |
152 | MARK3 | 0.38453409 |
153 | AKT3 | 0.37987635 |
154 | MAPK13 | 0.37724167 |
155 | CSNK1E | 0.37198272 |
156 | PRKCG | 0.37174074 |
157 | EGFR | 0.36996539 |
158 | PRKCI | 0.36930800 |
159 | TNK2 | 0.36727167 |
160 | MELK | 0.36233641 |
161 | CDK3 | 0.36003975 |
162 | PRKAA2 | 0.35595773 |
163 | PIK3CA | 0.35588511 |
164 | STK39 | 0.35537248 |
165 | CSNK1D | 0.34975532 |
166 | CDK1 | 0.34379369 |
167 | JAK2 | 0.33482855 |
168 | PRKDC | 0.33376602 |
169 | ERBB2 | 0.32852097 |
170 | MST4 | 0.32590091 |
171 | IRAK1 | 0.32584980 |
172 | MAP2K7 | 0.31464892 |
173 | GRK5 | 0.31132521 |
174 | DMPK | 0.30519521 |
175 | DYRK1A | 0.30172927 |
176 | MAPK3 | 0.29466720 |
177 | MAP3K11 | 0.29132832 |
178 | MAPKAPK2 | 0.28882701 |
179 | VRK1 | 0.28827420 |
180 | MAPK11 | 0.28042423 |
181 | MARK2 | 0.27967417 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.42100953 |
2 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.44966314 |
3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.44663841 |
4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37196222 |
5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.35372361 |
6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.32379724 |
7 | Ribosome_Homo sapiens_hsa03010 | 2.28910048 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.24063673 |
9 | Platelet activation_Homo sapiens_hsa04611 | 2.16111080 |
10 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.14821781 |
11 | Thyroid cancer_Homo sapiens_hsa05216 | 2.13139494 |
12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.11504342 |
13 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.09194127 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.08427403 |
15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.02373861 |
16 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.96645202 |
17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.96635500 |
18 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.96081073 |
19 | Homologous recombination_Homo sapiens_hsa03440 | 1.95235861 |
20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.93758977 |
21 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.90450286 |
22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.88102727 |
23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.87314401 |
24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.86639431 |
25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.84460383 |
26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.83291140 |
27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.81053373 |
28 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.79160105 |
29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.74249770 |
30 | Proteasome_Homo sapiens_hsa03050 | 1.71376279 |
31 | Shigellosis_Homo sapiens_hsa05131 | 1.70325819 |
32 | * Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.69116198 |
33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.68383640 |
34 | RNA polymerase_Homo sapiens_hsa03020 | 1.61983647 |
35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59812787 |
36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59017185 |
37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.58208585 |
38 | Pertussis_Homo sapiens_hsa05133 | 1.57569657 |
39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.55609302 |
40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.52179171 |
41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52169540 |
42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.51906331 |
43 | RNA transport_Homo sapiens_hsa03013 | 1.47002946 |
44 | Mismatch repair_Homo sapiens_hsa03430 | 1.42373553 |
45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42237890 |
46 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.41222105 |
47 | RNA degradation_Homo sapiens_hsa03018 | 1.37015662 |
48 | Legionellosis_Homo sapiens_hsa05134 | 1.36952938 |
49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.36383058 |
50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.34920538 |
51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28610359 |
52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.28207335 |
53 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28137755 |
54 | DNA replication_Homo sapiens_hsa03030 | 1.28096629 |
55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27517671 |
56 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26237648 |
57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.25477662 |
58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.25065625 |
59 | Cell cycle_Homo sapiens_hsa04110 | 1.24709970 |
60 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.24435200 |
61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.22639904 |
62 | ABC transporters_Homo sapiens_hsa02010 | 1.22491718 |
63 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19191879 |
64 | Measles_Homo sapiens_hsa05162 | 1.18783868 |
65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17213252 |
66 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.16900239 |
67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.16313084 |
68 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.14467726 |
69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14434926 |
70 | Spliceosome_Homo sapiens_hsa03040 | 1.13957986 |
71 | Phototransduction_Homo sapiens_hsa04744 | 1.13066632 |
72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12469033 |
73 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.12215566 |
74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10206584 |
75 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08448192 |
76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.08345655 |
77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.08328752 |
78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07735401 |
79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06155929 |
80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05728569 |
81 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05710453 |
82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.05543661 |
83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.04741043 |
84 | Salmonella infection_Homo sapiens_hsa05132 | 1.04350309 |
85 | Influenza A_Homo sapiens_hsa05164 | 1.04085151 |
86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.03294013 |
87 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03169699 |
88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01609811 |
89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00777484 |
90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00570252 |
91 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.98505850 |
92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96775113 |
93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.95359962 |
94 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95276270 |
95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93139076 |
96 | Hepatitis C_Homo sapiens_hsa05160 | 0.93048382 |
97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92972869 |
98 | Lysine degradation_Homo sapiens_hsa00310 | 0.92584833 |
99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91721294 |
100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89682746 |
101 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.87217526 |
102 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86800164 |
103 | Purine metabolism_Homo sapiens_hsa00230 | 0.86044283 |
104 | Malaria_Homo sapiens_hsa05144 | 0.85702782 |
105 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.85687111 |
106 | Tuberculosis_Homo sapiens_hsa05152 | 0.85173911 |
107 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84174513 |
108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.83437114 |
109 | Hepatitis B_Homo sapiens_hsa05161 | 0.83035955 |
110 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81582709 |
111 | Base excision repair_Homo sapiens_hsa03410 | 0.81322822 |
112 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.79762379 |
113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77759068 |
114 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77529068 |
115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76998319 |
116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75926902 |
117 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.75429593 |
118 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74057533 |
119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73603107 |
120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.73294244 |
121 | Huntingtons disease_Homo sapiens_hsa05016 | 0.71897998 |
122 | Peroxisome_Homo sapiens_hsa04146 | 0.71820668 |
123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70871955 |
124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70050994 |
125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.69736709 |
126 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.69512639 |
127 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68877441 |
128 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67649701 |
129 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67064016 |
130 | Tight junction_Homo sapiens_hsa04530 | 0.66017521 |
131 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63939793 |
132 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63130372 |
133 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62067725 |
134 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60848474 |
135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60790087 |
136 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.60659576 |
137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60565241 |
138 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60050154 |
139 | Adherens junction_Homo sapiens_hsa04520 | 0.59539910 |
140 | Apoptosis_Homo sapiens_hsa04210 | 0.58551551 |
141 | Insulin resistance_Homo sapiens_hsa04931 | 0.57586802 |
142 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57407235 |
143 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56111102 |
144 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53192838 |
145 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52579692 |
146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52127214 |
147 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49634578 |
148 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48219568 |
149 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48160204 |
150 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48117750 |
151 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47674803 |
152 | Mineral absorption_Homo sapiens_hsa04978 | 0.47422762 |
153 | Nicotine addiction_Homo sapiens_hsa05033 | 0.45581967 |
154 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.44947256 |
155 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44410392 |
156 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43697011 |
157 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43072491 |
158 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42464033 |
159 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41880681 |
160 | Taste transduction_Homo sapiens_hsa04742 | 0.40793057 |
161 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40786056 |
162 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39823596 |
163 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39576165 |
164 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36549313 |
165 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36110807 |
166 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.35597564 |
167 | Allograft rejection_Homo sapiens_hsa05330 | 0.35299224 |
168 | Protein export_Homo sapiens_hsa03060 | 0.35116387 |
169 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.32515628 |
170 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32213140 |
171 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31789833 |
172 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31775709 |
173 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31671651 |
174 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31276320 |